Health Surveillance & Disease Prevention & Control — Communicable Diseases: 
Acute Respiratory Infections - Anthrax - Antimicrobial Resistance - Campylobacter - Chagas -
Cholera - Dengue - Diarrheal/Enteric Diseases - Disease Outbreak News -
Emerging/Reemerging Diseases - Filariasis - Hantavirus - Influenza: Avian |  Pandemic |  Seasonal - International Health Regulations - Leishmaniasis - Leprosy - Malaria -
Neglected Diseases - Parasitic Diseases - Rabies - Research - Salmonella - Shigella - Smallpox -
Tuberculosis - West Nile Virus  - Yellow Fever  -
Health Analysis & Statistics - Chronic Diseases - Veterinary Public Health

Lymphatic Filariasis Elimination in the Americas:

5^th Regional Program Managers' Meeting, 4^th Regional Program Review Group Meeting

(Paramaribo, Suriname, 26–29 October 2004)

Full-Text Meeting Report (PDF, 163 pp, 4.53 Mb, contents below; all PowerPoint presentations are included in the corresponding chapter in a text adaptation, with graphics)

• Introduction, Orientation, and Review of Agenda
  Meeting Agenda
• Country Presentations: Progress Reports and 2005 Plan of Action Outlines
  • Brazil
  • Dominican Republic
  • Guyana
  • Haiti
  • Costa Rica
  • Trinidad & Tobago
• Special Topics: Program Updates
  • GPELF: Report from WHO Global Programme for the Elimination of LF—Progress, Financing, Directions
  • GAELF: New Structure of the Global Alliance for the Elimination of Lymphatic Filariasis: Post-Cairo
• Special Topic: Operational Research
  • Validation of Tools: Preliminary PCR and Xenomonitoring Results from Belém, Pará, Brazil
  • Entomological Successes
  • HealthMapper in Brazil
• Group Discussion
• Group Guidelines
• Group Presentations
  • Group 1: Preparations and Processes for the Interruption of LF Transmission
  • Group 2: Advances in Disease Control Efforts in the Americas
  • Group 3: Monitoring and Evaluation for Impact and Surveillance: Issues before the National Program Managers
• Special Topic: Integration of LF Elimination with Other Disease Control/Elimination Efforts
  • Integration
  • Neglected Diseases: New Approaches to Reshaping the Determinants of Health and Sustainable Development
• Wrap-Up, Highlights, and Perspectives

• Meeting Agenda
• Review of 2005 National Plans of Action
  • Dominican Republic
  • Haiti
  • Discussion and Presentation of Table of Drug Forecasts
  • Brazil
  • Guyana
  • Costa Rica, Suriname, and Trinidad & Tobago: Verification of Absence of Transmission
• Monitoring & Evaluation
  • Country with the DEC-Salt Strategy: Guyana
• Other Key Themes
• The Morbidity Element of the LF Elimination Strategy in the Americas: Activities and Future Directions
• Mapping Using HealthMapper: Issues and Future Directions
• Report on Visit to China for Evaluating Certification for LF Elimination
• Impact of Natural Disasters on the LF Elimination Programs: Hurricanes Ivan and Jeanne
• Report on Situation of LF in Haitian Refugees in Jamaica
• Communications Strategies to Meet the Needs of the RPRG and Question of Selection of Regional Representation in the GAELF RCG
• Other Issues and Topics of Interest
  • Report from Global Partner GSK
  • Entomological Successes: Part II
  • Action Points
• Appendix
  1. Participant List
  2. Acronyms and Abbreviations
  3. RPRG Membership and Terms of Reference
  4. RPRG Members
  5. Outline for Verification of Absence of Transmission